Expression of the N-myc oncogene in Wilms' tumour and related tissues.
Tissue samples and cell cultures from Wilms' tumour matched histologically normal kidney samples and EBV transformed B cells from the same patients, were analysed to detect changes in the structure and expression of the N-myc oncogene. The levels of expression of HLA class I and hypoxanthine guanine phosphoribosyl transferase were also measured in the various RNA preparations. Related tissue samples, from sources including congenital mesoblastic nephroma, paediatric neuroblastoma and a number of foetal tissues were also tested. Northern blot analysis indicated that the levels of N-myc were higher in Wilms' tumour tissues (with no parallel increase in gene copy number) compared to all other sources of material including foetal kidney. Particularly high levels of expression were observed in a number of the Wilms' tumours, several of which produced metastases. In situ hybridization, using [35S]-labelled RNA probes, confirmed that the high levels of N-myc RNA were present in the blastemal elements in the Wilms' tumour. All the tissue cultures, and tissue samples from other sources, except foetal brain and neuroblastoma, contained uniformly low levels of N-myc RNA.
Shaw
A P
AP
Cancer and Leukaemia in Childhood Trust Research Unit, University of Bristol, UK.
Poirier
V
V
Tyler
S
S
Mott
M
M
Berry
J
J
Maitland
N J
NJ
D002648:Child; D002675:Child, Preschool; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D007223:Infant; D007680:Kidney Neoplasms / Q000235:genetics*; D009857:Oncogenes; D012333:RNA, Messenger / Q000032:analysis; D014407:Tumor Cells, Cultured; D009396:Wilms Tumor / Q000235:genetics*
D006680:HLA Antigens; D012333:RNA, Messenger; D007041:Hypoxanthine Phosphoribosyltransferase